Cilengitide in Treating Patients With Prostate Cancer
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well cilengitide works in treating patients with prostate
cancer. Cilengitide may stop the growth of prostate cancer by blocking blood flow to the
tumor